News
HOOKIPA Pharma Inc. (NASDAQ: HOOK, 'HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation ...
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on July 16, 2025 it granted stock options to purchase an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback